These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 4893831

  • 1. Prevention of clinical and subclinical rubella infection. Efficacy of three HPV-77 derivative vaccines.
    Detels R, Grayston JT, Kim KS, Chen KP, Gale JL, Beasley RP, Gutman L.
    Am J Dis Child; 1969 Aug; 118(2):295-300. PubMed ID: 4893831
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prevention of rubella during an epidemic on Taiwan. HPV-77 and RA 27-3 rubella vaccines administered subcutaneously and intranasally HPV-77 vaccine mixed with mumps and-or measles vaccines.
    Beasley RP, Detels R, Kim KS, Gale JL, Lin TL, Grayston JT.
    Am J Dis Child; 1969 Aug; 118(2):301-6. PubMed ID: 4893832
    [No Abstract] [Full Text] [Related]

  • 4. Field trial of live attenuated rubella virus vaccine during an epidemic on Taiwan. Preliminary report of efficacy of three HPV-77 strain vaccines in the prevention of clinical rubella.
    Grayston JT, Detels R, Chen KP, Gutman L, Kim KS, Gale JL, Beasley RP.
    JAMA; 1969 Feb 10; 207(6):1107-10. PubMed ID: 4884671
    [No Abstract] [Full Text] [Related]

  • 5. Children immunized with HPV-77 rubella vaccine. Additional laboratory observations.
    Katz SL, Lang DJ, Wilfert CM, Feigin RD, Goldfein M.
    Am J Dis Child; 1969 Aug 10; 118(2):213-7. PubMed ID: 4893822
    [No Abstract] [Full Text] [Related]

  • 6. Rubella virus vaccine (HPV-77-DE 5). Antigenic and protective efficacy in a community trial.
    McCollum RW, Randolph MF, Byrne EB, Hilleman MR.
    Am J Dis Child; 1969 Aug 10; 118(2):186-9. PubMed ID: 4893821
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Attenuated rubella virus vaccines in children with tuberculosis. Clinical trials.
    Boué A, Celers J.
    Am J Dis Child; 1969 Aug 10; 118(2):258-60. PubMed ID: 4893827
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Reinfection with rubella virus despite live vaccine induced immunity. Trials of HPV-77 and HPV-80 live rubella virus vaccines and subsequent artificial and natural challenge studies.
    Wilkins J, Leedom JM, Portnoy B, Salvatore MA.
    Am J Dis Child; 1969 Aug 10; 118(2):275-94. PubMed ID: 5794818
    [No Abstract] [Full Text] [Related]

  • 13. Attenuated rubella viruses. Laboratory and clinical characteristics.
    Meyer HM, Parkman PD, Hobbins TE, Larson HE, Davis WJ, Simsarian JP, Hopps HE.
    Am J Dis Child; 1969 Aug 10; 118(2):155-65. PubMed ID: 4978508
    [No Abstract] [Full Text] [Related]

  • 14. Clinical evaluation of rubella vaccine, Cendehill strain.
    Farquhar JD.
    South Med J; 1970 Apr 10; 63(4):371-5. PubMed ID: 4908607
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Rubella vaccines.
    Lancet; 1970 Jan 17; 1(7638):127-8. PubMed ID: 4188730
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.